Your browser doesn't support javascript.
loading
Downregulation of pro-surfactant protein B contributes to the recurrence of early-stage non-small cell lung cancer by activating PGK1-mediated Akt signaling.
Luo, Hao; Li, Qing; Wang, Ren-Tao; Zhang, Liang; Zhang, Wei; Deng, Meng-Sheng; Luo, Yuan-Yuan; Ji, Xintong; Wen, Yongheng; Zhou, Xuan-Rui; Xu, Bo; Wang, Dong; Hu, Bin; Jin, Hua; Xu, Cheng-Xiong.
Afiliação
  • Luo H; School of Medicine, Chongqing University, Chongqing, 400030, China.
  • Li Q; Cancer Center, Daping Hospital, Army Medical University, Chongqing, 400042, China.
  • Wang RT; School of Medicine, Chongqing University, Chongqing, 400030, China.
  • Zhang L; Cancer Center, Daping Hospital, Army Medical University, Chongqing, 400042, China.
  • Zhang W; College of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing, China.
  • Deng MS; Department of Thoracic Surgery, Daping Hospital, Army Medical University, Chongqing, 400042, China.
  • Luo YY; Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, 610041, China.
  • Ji X; State Key Laboratory of Trauma Burn and Combined Injury, Daping Hospital, Army Medical University, Chongqing, 400042, China.
  • Wen Y; School of Medicine, Chongqing University, Chongqing, 400030, China.
  • Zhou XR; School of Medicine, Chongqing University, Chongqing, 400030, China.
  • Xu B; School of Medicine, Chongqing University, Chongqing, 400030, China.
  • Wang D; School of Medicine, Chongqing University, Chongqing, 400030, China.
  • Hu B; Chongqing Key Laboratory of Intelligent Oncology for Breast Cancer, Chongqing University Cancer Hospital and Chongqing University School of Medicine, Chongqing, 400030, China.
  • Jin H; Cancer Center, Daping Hospital, Army Medical University, Chongqing, 400042, China.
  • Xu CX; Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, 610041, China. hubin@scszlyy.org.cn.
Exp Hematol Oncol ; 12(1): 94, 2023 Nov 09.
Article em En | MEDLINE | ID: mdl-37946295

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Exp Hematol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Exp Hematol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido